She is also actively involved in public organizations at the national level, such as the Expert Board of the Association of Indonesian Pharmacy Higher Education and the Health Technology Assessment Committee Ministry of Health (MoH). She also has extensive professional experience, including serving as a member of the Policy Review Team, Coordinating Ministry for Human Development and Cultural Affairs, and Board Member of the National Collegium of Pharmacy. She is also frequently invited to serve as an external expert by the Ministry of Health (MoH), the Indonesian Food and Drug Authority (BPOM), and various other government ministries and agencies. In the area of pharmacovigilance, she was trusted to be involved in a big data analysis under the Indonesian FDA (BPOM) national Post-Authorization Safety Study (PASS) for favipiravir and remdesivir during the COVID-19 pandemic, as well as PASS for the Covovax funded by PT Indofarma, Tbk.
She is dedicated to advancing pharmaceutical and public health research, strengthening evidence-based policymaking, and improving healthcare outcomes through academic leadership, community engagement, and multidisciplinary collaboration.
For inquiries, Prof Rani can be contacted at:
rani@farmasi.ui.ac.id
IG@ranisauriasari